Abbvie Sculpts Position In Aesthetics Space With Allergan Acquisition
Executive Summary
Abbvie is taking on Allergan's aesthetics portfolio as part of its $63bn takeover deal. The acquisition includes Allergan's CoolSculpt body contouring system and a new FDA-approved device for muscle strengthening.